Call for Public Comments on the Switch to OTC for Candidate Ingredients

Regarding the candidate ingredient "celecoxib",
we plan to gather opinions from the general public on its efficacy and effects when switched to OTC,
the needs for it as an OTC product,
how it would be used if switched to OTC,
and the challenges and countermeasures for the switch to OTC,
and discuss these at future review meetings.

Ingredient Information Sheet for Celecoxib

Package insert for Celecox Tablets 100mg and 200mg
Interview form for Celecox Tablets 100mg and 200mg

Submission deadline: October 12, 2025, at 0:00 AM